Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 10Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Uterine Cervical Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Small Cell Lung Carcinoma 1Sarcoma 1Retinoblastoma 1Prostatic Neoplasms 1Platinum-Refractory Fallopian Tube Carcinoma 1Neuroblastoma 1Neoplasm Metastasis 1Lymphoma 1Lung Neoplasms 1Glioma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Advanced Solid Tumors 1

Interventions

Rituximab 20Cyclophosphamide 18Etoposide 11Vincristine 10Doxorubicin 10fludarabine phosphate 9Prednisone 9Filgrastim 9Radiotherapy 8Peripheral Blood Stem Cell Transplantation 8Cytarabine 8Methotrexate 7Melphalan 7Dexamethasone 6fludarabine 4Cyclosporine 4Antilymphocyte Serum 4duvelisib 3belinostat 3Thiotepa 3Tacrolimus 3Nivolumab 3Mycophenolic Acid 3Lenalidomide 3Ifosfamide 3Gemcitabine 3Carmustine 3Busulfan 3Alemtuzumab 3sargramostim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Lymphoma × Topotecan × Clear all
NCT00109798 2017-09-19

Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma

The Methodist Hospital Research Institute

Phase NA Withdrawn
CNSLymphoid

Lymphoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡